MedPath
HSA Approval

CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL

SIN15018P

CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL

CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL

May 25, 2016

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DB04

cefazolin

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Qilu Pharmaceuticals Co. Ltd

Active Ingredients

CEFAZOLIN SODIUM 524MG EQV TO CEFAZOLIN BASE

500MG

Cefazolin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CEFAZOLIN-AFT POWDER FOR INJECTION 500MG/VIAL - HSA Approval | MedPath